p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p21 is required for a sustained G(2) arrest after activation of the DNA damage checkpoint. Here we have addressed the mechanism by which p21 can contribute to this arrest in G(2). We show that p21 blocks the activating phosphorylation of Cdc2 on Thr(161). p21 does not interfere with the dephosphorylation of two inhibitory phosphorylation sites on Cdc2, Thr(14) and Tyr(15), indicating that p21 targets a different event in Cdc2 activation as the well described DNA damage checkpoint pathway involving Chk1 and Cdc25C. Taken together our data show that a cell is equipped with at least two independent pathways to ensure efficient inhibition of Cdc2 activity in response to DNA damage, influencing both positive and negative regulatory phosphorylation events on Cdc2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“even after its overexpression in U2OS osteosarcoma cancer cells, p21 only weakly associated with cyclin B1-Cdk1).58”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [58]
In the citing paper
“They elegantly confirmed and extended previous observations 58,69 and pinpointed this event as the first step in triggering the G2 exit program, resulting in permanent cell cycle withdrawal (Fig. 3).”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [58]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Boyle, W. J., van der Geer, P., & Hunter, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01013-r · Cited by 1,434
Cyclin A is required at two points in the human cell cycle.
Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., & Draetta, G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05135.x · Cited by 1,403
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Research works printed but not linked: 1
- Li, 1994, Oncogene, 9, 2261
Cited by
Items 201–231 of 231
Alaoui‐Jamali, M. A., Wurzba, S. D., & Bijian, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803582-5.00010-3
Induction de la voie IFN/STAT1 dans le cancer du sein sous chimiothérapie : étude mécanistique
Gaston, J. (2016) · theses.fr (ABES) · doi:10.70675/f12f01b9z1813z4194z828cz931e4998f8d1
Analysis of radio-sensitization patents in China from 2006 to 2015
He, G., Di, X., Sun, X., Yan, J., & Zhang, S. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1344222
Targeting BRCA1 and p53 family of tumor supressors in cancer treatment
Raimundo, L. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/2hmm-5365
Bi, G., Liang, J., Zhao, M., Zhang, H., Jin, X. Y., Lu, T., Zheng, Y., Bian, Y., Chen, Z., Huang, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3957113
Carcinogenèse et transit cytonucléaire de la protéine ATM
Nachef, L. E. (2024) · theses.fr (ABES) · doi:10.70675/f1066ae0z6a21z4f83zadb1z08eac469093b
Punga, T. (2003) · DiVA (Digitala Vetenskapliga Arkivet)
Kommer, D. C. (2024) · Brunel University Research Archive (BURA) (Brunel University London)
Hang, X., Macino, M., Woitaske-Proske, C., Bodenstein, N., Bernardes, J. P., Tran, F., Schmid, N. A., Martini, G. R., Wottawa, F., Bornhaeuser, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.17.706442
Repositionnement d'un inhibiteur de métalloprotéases dans le cancer du sein
M'Hidi, L. M. (2013) · theses.fr (ABES) · doi:10.70675/60108424z3ec9z4cb2zaa9bz4385d4349805
Mécanismes orchestrant la sortie du cycle cellulaire opérant en G2
Lossaint, G. (2010) · theses.fr (ABES) · doi:10.70675/73a8a635z0ba0z466bza623zfba090ad12ce
Rôle de la protéine multifonctionnelle E4F1 et de la voie p53 dans l’homéostasie cutanées
Goguet-Rubio, P. (2013) · theses.fr (ABES) · doi:10.70675/cf006e65z80d3z43f4za521z25580e174bc9
Tichet, M. (2013) · theses.fr (ABES) · doi:10.70675/22b4e5efz84fdz4c9cz88d0zdcf7f372747b
Création d'un système rapporteur pour l'étude de mutations de p53
Parrot, C. (2016) · theses.fr (ABES) · doi:10.70675/915babb6zcdccz47f7z9751zbc9df476006e
Bačević, K. (2016) · theses.fr (ABES) · doi:10.70675/11789f75zbd23z4799zacfbzd7a0d55a3fd3
Ferlazzo, M. L. (2017) · theses.fr (ABES) · doi:10.70675/047a4478z349cz4abbz8e47z6c146188b83b
In vitro anticancer activity of new gold (III) porphyrin complexes in colon cancer cells
Dandash, F. (2017) · theses.fr (ABES) · doi:10.70675/60fa7f9eze779z4987zb9ddzcda472eefe05
Bachelet, J.-T. (2020) · theses.fr (ABES) · doi:10.70675/3c3e2db9zfde9z4fa4zab19z1ce729143190
Locquet, M.-A. (2021) · theses.fr (ABES) · doi:10.70675/1e88c1e9ze630z4047z8058zb88b9e41c6eb
Origins of Cellular Lethality Resulting From a Defect in Homologous Recombination in Human Cells
THOMAS, M. L. (2021) · theses.fr (ABES) · doi:10.70675/294f7c6bz644bz42ddz8fb3zffd32551bc76
Restier-Verlet, J. (2024) · theses.fr (ABES) · doi:10.70675/8cde5bf9z2a14z4341z9c08zd3697212dcec
Jin, X., Li, Y., Zhang, R., Yang, Y., Han, A., Jin, X., Zhang, S., Quan, C., Lin, Z., & Lin, X. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s594336
“76 Studies have demonstrated that high-Z MNPs can enhance the radiosensitivity of tumor cells several-fold through these cell cycle arrest processes.”
Terpenoids as modulators of autophagy-senescence crosstalk in lung cancer
Niharika, K., Nagakanni, M., Das, M., & Kiruthiga, C. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00634-w
Randall, L. J., Tran, T. D., Siddals, G., Harvey, V. L., Greensill, A., Woodhill, K. E., & Russell, F. D. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05771-z
The Role of ERK5 in Cell Proliferation
Madrigal, D. P. (2013) · Research Explorer (The University of Manchester)
Role of p53 and its isoforms in the expression of FGF-2 and tumoral neovascularization
Bernard, H. (2010) · Discovery Research Portal (University of Dundee)
Scrable, H. J., & Ashrafzadeh‐Kian, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7696-2_25
Metadata
- Authors
- Smits, V. A. J., Klompmaker, R., Vallenius, T., Rijksen, G., Mäkelä, T. P., & Medema, R. H.
- Affiliations
- University Medical Center Utrecht (NL)
- University of Helsinki (FI)
- Corresponding author
- Medema, René H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-09
- Volume
- 275
- Issue
- 39
- Pages
- 30638-30643
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2127397312
- Cited by
- 221
- References
- 41
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 7 · 2019: 6 · 2018: 4 · 2017: 12 · 2016: 14 · 2015: 7 · 2014: 6 · 2013: 14 · 2012: 14
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7349 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p21, cdc2, G2 checkpoint, DNA damage checkpoint, G2 cell cycle arrest, cyclin-dependent kinase inhibition, Chk1, Cdc25C, cell cycle regulation
- MeSH terms
- Cell Compartmentation, Cell Nucleus, DNA Damage, Models, Biological, Phosphorylation, Protein Binding, Threonine, G2 Phase, CDC2 Protein Kinase, Cyclins, Cyclin-Dependent Kinases, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.